About SharpBrains:

After recently obtaining the ISO 13485 certification for its quality system management system for medical devices, HAPPYneuron is proud to announce its partnership with the renowned pharma lab Merck KGaA. HAPPYneuron grants an exclusive license on a cognitive training program for people living with Multiple Sclerosis (MS). This Class 1 medical device is available in Merck’s « MSDialog » platform when deemed beneficial for a patient by his/her healthcare provider.

For Merck KGaA : “The HAPPYneuron software-based cognitive training is backed by more than 10 years of clinical data and is designed to address cognitive function across various domains. HAPPYneuron’s suite of cognitive training games are designed to address the cognition challenges that people living with MS face, and the games automatically adjust skill to match the need of the individual — making the platform interesting for the patient and simple for healthcare professionals to use with their patients.” To access Merck’s press release.

HAPPYneuron is proud to contribute to this project designed to help people living with MS and confirms its expertise in cognitive remediation. Franck Tarpin-Bernard, HAPPYneuron President, says “This agreement is a strong acknowledgement of the hard work we have achieved these past years to build training programs adapted to the uniqueness of each medical condition. It reinforces our willingness to become a world leader of digital cognitive remediation.”

About Merck KGaA

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

HAPPYneuron Pro will be attending the ASHA (American Speech and Hearing Association) annual convention in Denver, Colorado on November 12th to 14th, 2015. This event is the most important show for Speech and Language Therapists and Audiologists in the US.

This annual meeting gathers over 12,000 visitors and 300 exhibitors from all over the world and is a great opportunity to share and learn the last trends and evolution in this market. Change is a central theme of this event: « Changing Minds. Changing Lives. Leading the Way ».

HAPPYneuron Pro will be exhibiting during this 3-day event and presenting its latest products. The perfect place to continue its expansion in the US and promote HAPPYneuron worldwide.

Find out more in the detailed agenda of the convention: http://www.asha.org/Events/convention/Schedule

HAPPYneuron, major actor in the field of cognitive remediation tools, along with Doctor Marc Willard, Psychiatrist, author of “Depression at the workplace”, and “Treating depression at the workplace with CBT” are proud to announce the release of the CES-D application to screen for depression.

Depression is a very frequent illness that can affect anybody. One person out of 5 will be affected during his/her lifetime. Its diagnosis is often late or unknown. However this illness can be treated efficiently with antidepressant or psychotherapy.

This CES-D application allows you to take a quick screening test, based on 20 questions taken from the most widely used auto-evaluation scale in depression epidemiology. This test does not provide a diagnosis, but can help detect potential depression-related disorders, with a simple self evaluation.

CES-D is available for free on Google Play and on the AppStore.

On June 6th 2014 in New York was held the 17th annual conference on “Cognitive Remediation in Psychiatry”. This international conference, organized by the Columbia University, brings together researchers, physicians, organizations and companies from all around the world.

HAPPYneuron is proud to have taken part in this event and in discussions on various topics relating to social and cognitive remediation for people with psychiatric disorders.

The event’s program included presentations by researchers on their experiences and research findings about cognitive remediation, themed workshops, training on remediation, and many poster presentations on current and future research.

Chris Bowie, professor and researcher at Queens University in Canada, presented the preliminary results of a recent study using our tools as part of a program to help people with schizophrenia in their professional lives.

Isabelle Amado from the Saint-Anne hospital in Paris, was also awarded a prize entitled “Science to Practice” for her invaluable contribution to cognitive remediation and its expansion in France, Europe and internationally.

Many workshops were also held, and SBTpro was mentioned and recognized as one of the essential tools for cognitive remediation.

HAPPYneuron was pleased to sponsor this event to support research in this area and to advance the knowledge and use of these treatments for Schizophrenia.